Video
Preventive pharmacological therapy is beneficial in patients with recurrent stones when using 24-hour urine testing
Author(s):
“The take home message would be that in patients with prior history of kidney stone episodes…receiving 24-hour urine testing prior to starting pharmacologic preventive therapy is associated with a lower probability of a subsequent stone-related event,” says Ryan Hsi, MD, FACS.
In this video, Ryan Hsi, MD, FACS, discusses the recent Urology study, “Comparison of Selective Versus Empiric Pharmacologic Preventive Therapy of Kidney Stone Recurrence with High-Risk Features,” for which he served as first author. Hsi is an associate professor of urology at Vanderbilt University Medical Center in Nashville, Tennessee.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
